CVS Health Corp. stock gains 0.76 percent pre-market to EUR 82.34

Published on 10/16/2026 at 07:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At Lang & Schwarz on October 16, 2026, CVS Health Corp. stock is at EUR 82.34 pre-market, 0.76 percent above the October 15 Xetra close. The next dated item is October 22, 2026.

Dates and valuation ahead

The next dated item is CVS Health's October 22, 2026 ex-dividend date.
CVS Health Corp. stock trades pre-market at EUR 82.34 at 7:37 a.m. CEST at Lang & Schwarz on October 16, 2026, 0.76 percent above the Xetra close of October 15, 2026, at EUR 81.72.
Leerink Partners' October 12, 2026 price target was lowered to USD 112.00.

Extreme Nahaufnahme bunter pharmazeutischer Kapseln und Tabletten mit Bokeh-Hintergrund — CVS Health Corp. Makroaufnahme zeigt bunte Pharmakapseln und Tabletten in Detailansicht, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health Corp. stock trades pre-market at EUR 82.34 at 7:37 a.m. CEST at Lang & Schwarz on October 16, 2026. The price is 0.76 percent above the Xetra close of October 15, 2026, at EUR 81.72.

Pre-market price

The Lang & Schwarz bid was EUR 82.14 and the ask was EUR 82.54. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of CVS Health Corp. stock.

What matters today

The next dated item is CVS Health's October 22, 2026 ex-dividend date, according to Yahoo Finance. The next reference level is the Xetra close of EUR 81.72, 0.76 percent below the Lang & Schwarz price. Leerink Partners' October 12, 2026 price target was lowered to USD 112.00, the same source reports.

Market reference

Yahoo Finance listed CVS Health's market capitalization at USD 115.606 billion, a 52-week range of USD 69.51 to USD 110.68, and a trailing price-to-earnings ratio of 23.06. The page also listed a 3.04 percent forward dividend yield.

Market context: Market report S&P 500.

More news and analysis on CVS Health stock